相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes
Stella Bernardi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis
Rachel Knevel et al.
ARTHRITIS RESEARCH & THERAPY (2014)
The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritis
Rachel Audo et al.
CYTOKINE (2013)
Osteoprotegerin Exerts Its Pro-inflammatory Effects Through Nuclear Factor-κB Activation
Lily Nahidi et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
First-Year Radiographic Progression as a Predictor of Further Progression in Early Arthritis: Results of a Large National French Cohort
Gabriel Tobon et al.
ARTHRITIS CARE & RESEARCH (2013)
Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort
Magali Meyer et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Mechanisms and Clinical Relevance of TRAIL-Triggered Responses in the Synovial Fibroblasts of Patients With Rheumatoid Arthritis
Rachel Audo et al.
ARTHRITIS AND RHEUMATISM (2011)
A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study
K. Visser et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis
Nathan Vastesaeger et al.
RHEUMATOLOGY (2009)
Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway
Estelle Chamoux et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study
Natacha Courvoisier et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Investigating the interaction between osteoprotegerin and receptor activator of NF-κB or tumor necrosis factor-related apoptosis-inducing ligand
Srdjan Vitovski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The ESPOIR cohort: A ten-year follow-up of early arthritis in France: Methodology and baseline characteristics of the 813 included patients
Bemard Combe et al.
JOINT BONE SPINE (2007)
Apo2L/TRAIL and immune regulation
Alberto Anel et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis
Silvia Colucci et al.
APOPTOSIS (2007)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt
J Morel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice
G Schett et al.
ARTHRITIS AND RHEUMATISM (2003)
Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice
SE Lamhamedi-Cherradi et al.
NATURE IMMUNOLOGY (2003)
Anticitrullinated protein/pepticle antibody assays in early rheumatoid arthritis for predicting five year radiographic damage
O Meyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Tumor necrosis factor-related apoptosis-inducing ligand induces, apoptosis in human articular chondrocytes in vitro
I Pettersen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression
KM Song et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
